Compound Detail
CHEMBL5420699
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5420699 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | IQXYOBRFXKFOGL-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
432.5
MW (Da)
5.15
ALogP
8
HBA
2
HBD
86.8
PSA (Ų)
0.40
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| LNCaP C4-2 CHEMBL4296460 | IC50 | 4.75 | 4.75 | 17600.0 | 1 |
| PC-3 CHEMBL390 | IC50 | 4.61 | 4.61 | 24800.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| LNCaP C4-2 | IC50 | = | 17600.0 | nM | 4.75 | Cytotoxicity against human LNCaP C4-2 cells assessed as cell growth inhibition i... | 38092421 |
| PC-3 | IC50 | = | 24800.0 | nM | 4.61 | Cytotoxicity against human PC-3 cells assessed as reduction in cell viability in... | 38092421 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 38092421 | 10.1021/acs.jmedchem.3c01130 | PC-3 | 1 |
| 38092421 | 10.1021/acs.jmedchem.3c01130 | LNCaP C4-2 | 1 |
Data from ChEMBL 36 via Core Engine